Efficacy of Moxibustion Therapy With or Without Smoke for Knee Osteoarthritis
A Multicentre, Randomised, Single Blinded, Parallel-group Study of Moxa Smoke Effect in Moxibustion Treating Knee Osteoarthritis
1 other identifier
interventional
138
1 country
1
Brief Summary
This is a multicentre, randomised, single blinded, parallel-group design clinical trial to assess the effect of moxa smoke in the treatment using moxibustion for Knee Osteoarthritis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable pain
Started May 2016
Longer than P75 for not_applicable pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2016
CompletedFirst Submitted
Initial submission to the registry
May 10, 2016
CompletedFirst Posted
Study publicly available on registry
May 13, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedFebruary 17, 2020
February 1, 2020
3 years
May 10, 2016
February 13, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in the global scale value of the Western Ontario and McMaster Osteoarthritis Index(WOMAC) score
4 weeks from baseline
Secondary Outcomes (3)
Change in the WOMAC subscales (pain, stiffness, and function)
at baseline(0 week), 2 weeks, 4weeks, 8 weeks and 12 weeks later after allocation
Mean change in Visual Analogue Scale for the pain intensity
Assessing participants at baseline(0 week), 2 weeks, 4weeks, 8 weeks and 12 weeks later after allocation
Change of Patient global assessment score
at 2 weeks, 4weeks, 8 weeks and 12 weeks later after allocation
Study Arms (2)
moxibustion group
EXPERIMENTALConventional moxibustion treatment for knee osteoarthritis participants.12 sessions of moxibustion treatment over a period of 4 weeks, 3 sessions per week.Each session will last 30 minutes.
smoke-free moxibustion group
EXPERIMENTALConventional moxibustion treatment for knee osteoarthritis participants and have a purification device at the top of the moxibustion to remove the moxa smoke.12 sessions of moxibustion treatment over a period of 4 weeks, 3 sessions per week.Each session will last 30 minutes.
Interventions
Moxibustion at three acupuncture point(EX-LE04,ST35,ST36).12 sessions of moxibustion treatment over a period of 4 weeks, 3 sessions per week.Each session will last 30 minutes.
Investigators place a purification device(Shenzhen Conyson Electronic Technology Co, Ltd,C200 moxa smoke purification device,Shenzhen,China) at the top of the moxibustion to remove the moxa smoke.
Eligibility Criteria
You may qualify if:
- Participants meeting the following criteria will be included:
- aged between 40 and 75 years
- diagnosed with knee osteoarthritis formulated by the American College of Rheumatology (ACR).
- the average severity of knee pain not more than 7 points on a visual analogue scale for most days during the past month
- agree not have the paregoric during the whole treatment phase
- willingness to participate in a randomized study and to sign the informed consent form.
You may not qualify if:
- Participants will be excluded if they have these experiences:
- inflammatory diseases, including rheumatoid arthritis, cancer, traumatic injury that might be related to the current knee pai
- autoimmune disease, uncontrolled hypertension
- diabetes mellitus requiring insulin injection
- life-threatening cardiovascular or neurological events within the past year
- chronic respiratory disease,a haemorrhagic disorder
- alcohol or drug addiction
- an active infectious disease including tuberculosis
- a significant knee joint deformity
- knee replacement surgery for the affected knee
- knee arthroscopy within the past year
- steroid injection in the knee joints within the past 3 months
- injections in the knee joints or joint fluid injection within the past 6 months
- accept acupuncture, moxibustion, cupping, or herbal medicine within the past 4 weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chengdu University of Traditional Chinese Medicine
Chengdu, Sichuan, 610075, China
Related Publications (2)
Luo L, Liao M, Peng JX, Ma Q, Zhou JY, Zhu LL, Wang X, Chen SS, Yin HY, Wu QF, Zhang CS, Lv P, Tang Y, Yu SG. Comparison of the Efficacy between Conventional Moxibustion and Smoke-Free Moxibustion on Knee Osteoarthritis: A Randomized Controlled Trial. Evid Based Complement Alternat Med. 2019 Mar 14;2019:1291947. doi: 10.1155/2019/1291947. eCollection 2019.
PMID: 31001350DERIVEDZhu LL, Zhou JY, Luo L, Wang X, Peng JX, Chen SS, Yin HY, Wu QF, Zhang CS, Lv P, Tang Y, Yu SG. Comparison of the efficacy between conventional moxibustion and smoke-free moxibustion on knee osteoarthritis: study protocol of a randomized controlled trial. Trials. 2017 Apr 24;18(1):188. doi: 10.1186/s13063-017-1846-2.
PMID: 28438185DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yu Shuguang, Professor
Chengdu University of Traditional Chinese Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 10, 2016
First Posted
May 13, 2016
Study Start
May 1, 2016
Primary Completion
May 1, 2019
Study Completion
December 1, 2019
Last Updated
February 17, 2020
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will not share